These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29031777)

  • 21. Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.
    Zheng Q; Cai X; Tan MH; Schaffert S; Arnold CP; Gong X; Chen CZ; Huang S
    Biotechniques; 2014; 57(3):115-24. PubMed ID: 25209046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CRISPR-Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection.
    Zhou W; Hu L; Ying L; Zhao Z; Chu PK; Yu XF
    Nat Commun; 2018 Nov; 9(1):5012. PubMed ID: 30479331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.
    Asano H; Toyooka S; Tokumo M; Ichimura K; Aoe K; Ito S; Tsukuda K; Ouchida M; Aoe M; Katayama H; Hiraki A; Sugi K; Kiura K; Date H; Shimizu N
    Clin Cancer Res; 2006 Jan; 12(1):43-8. PubMed ID: 16397022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chromosomal large fragment deletion induced by CRISPR/Cas9 gene editing system].
    Cheng LH; Liu Y; Niu T
    Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):427-431. PubMed ID: 28565744
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.
    He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J
    Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA fragment editing of genomes by CRISPR/Cas9.
    Li JH; Shou J; Wu Q
    Yi Chuan; 2015 Oct; 37(10):992-1002. PubMed ID: 26496751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
    Zhou Y; Zong Y; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
    Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
    J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus.
    Sakuma T; Masaki K; Abe-Chayama H; Mochida K; Yamamoto T; Chayama K
    Genes Cells; 2016 Nov; 21(11):1253-1262. PubMed ID: 27659023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein engineering of Cas9 for enhanced function.
    Oakes BL; Nadler DC; Savage DF
    Methods Enzymol; 2014; 546():491-511. PubMed ID: 25398355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas12a-based biosensing platform for precise and efficient screening of CRISPR/Cas9-induced biallelic mutants.
    Xiao G; Liu S; Liu H; He X; Zhang S; Liang Z; Guo H; Ou M; Zhou L; Liu L; Zhang T; Zhang G
    Talanta; 2020 Apr; 210():120613. PubMed ID: 31987174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.
    Bialk P; Sansbury B; Rivera-Torres N; Bloh K; Man D; Kmiec EB
    Sci Rep; 2016 Sep; 6():32681. PubMed ID: 27609304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CRISPR/Cas system can be used as nuclease for in planta gene targeting and as paired nickases for directed mutagenesis in Arabidopsis resulting in heritable progeny.
    Schiml S; Fauser F; Puchta H
    Plant J; 2014 Dec; 80(6):1139-50. PubMed ID: 25327456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.